The Biological Disease-Modifying Antirheumatic Drugs and the Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis

OBJECTIVE: To assess the association between the use of biological disease-modifying antirheumatic drugs (bDMARDs) and the risk of cardiovascular events in patients with systemic inflammatory conditions. METHODS: Eligible cohort studies or randomized controlled trials (RCTs) from inception to Januar...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Suiyuan, Lin, Chu, Cai, Xiaoling, Zhu, Xingyun, Lv, Fang, Nie, Lin, Ji, Linong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423578/
https://www.ncbi.nlm.nih.gov/pubmed/34504395
http://dx.doi.org/10.1155/2021/7712587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423578/
https://www.ncbi.nlm.nih.gov/pubmed/34504395
http://dx.doi.org/10.1155/2021/7712587

Ejemplares similares